III. Mechanism

  1. Cyclosporine is a Calcineurin Inhibitor with Immunosuppression and antiinflammatory properties (esp. inhibits T-Helper Cells)
  2. Improves tear production in autoimmune disorders (esp. Sjogren's Syndrome)

IV. Preparations

  1. Cyclosporine A 0.05% (Restasis) use 1 drop in each eye every 12 hours
    1. Wait for 10 minutes before inserting Contact Lenses after applying drop

Images: Related links to external sites (from Bing)

Related Studies

Cost: Medications

restasis (on 5/17/2017 at Medicaid.Gov Survey of pharmacy drug pricing)
RESTASIS 0.05% EYE EMULSION $7.45 each
RESTASIS MULTIDOSE 0.05% EYE $80.48 per ml

Ontology: Cyclosporine 0.5 MG/ML Ophthalmic Suspension (C1168858)

Concepts Clinical Drug (T200)
SnomedCT 407103000
English CYCLOSPORINE 0.05 % OPHTHALMIC DROPPERETTE, SINGLE-USE DROP DISPENSER, CYCLOSPORINE@0.05 %@OPHTHALMIC@DROPPERETTE, SINGLE-USE DROP DISPENSER, Cyclosporine 0.5 MG/ML Ophthalmic Suspension, CYCLOSPORINE 0.05% (PF) OPH EMUL 0.4ML, cyclosporine 0.05 % Ophthalmic Suspension, CYCLOSPORINE 0.05% OPHTHALMIC DROPPERETTE, SINGLE-USE DROP DISPENSER, CYCLOSPORINE@0.05%@OPHTHALMIC@DROPPERETTE, SINGLE-USE DROP DISPENSER, CYCLOSPORINE 0.05% DROPPERETTE, SINGLE-USE DROP DISPENSER, CYCLOSPORINE @ 0.05% @ DROPPERETTE, SINGLE-USE DROP DISPENSER, CYCLOSPORINE 0.05% (PF) EMULSION,OPH,0.4ML [VA Product], Cyclosporine 0.05% Ophthalmic drops, emulsion, cycloSPORINE 0.05 % Ophthalmic Suspension, cycloSPORINE 0.5 MG/ML Ophthalmic Suspension, Cyclosporine 0.05% Ophthalmic Emulsion, Cyclosporine (Ophth) Emulsion 0.05%, Cyclosporine ophthalmic emulsion 0.05% (product), Cyclosporine ophthalmic emulsion 0.05%, cycloSPORINE ophthalmic 0.05% ophthalmic emulsion, CYCLOSPORINE 0.05% (PF) EMULSION,OPH,0.4ML
Spanish ciclosporina, 0,05%, emulsión oftálmica (producto), ciclosporina, 0,05%, emulsión oftálmica

Ontology: Restasis (C1170584)

Concepts Pharmacologic Substance (T121) , Amino Acid, Peptide, or Protein (T116)
English Restasis, restasis

Ontology: Cyclosporine Ophthalmic Emulsion (C2699534)

Definition (NCI) An topical ophthalmic formulation containing cyclosporine, an undecapeptide produced by the fungus Beauveria nivea, with immunosuppressant and anti-inflammatory activities. The exact therapeutic mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release.
Concepts Pharmacologic Substance (T121)
English Cyclosporine Ophthalmic Emulsion